Patrick W Sullivan

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, University of Colorado School of Pharmacy, Denver, Colorado 80262, USA
    Med Care 41:1382-95. 2003
  2. ncbi The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, CO 80262, USA
    Pharmacoeconomics 24:1021-33. 2006
  3. pmc Preference-Based EQ-5D index scores for chronic conditions in the United States
    Patrick W Sullivan
    University of Colorado Department of Economics, Boulder, USA
    Med Decis Making 26:410-20. 2006
  4. pmc Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample
    Patrick W Sullivan
    University of Colorado School of Pharmacy, Pharmaceutical Outcomes Research Program, 4200 East Ninth Avenue, Box C238, Denver, CO 80262, USA
    Med Decis Making 26:401-9. 2006
  5. ncbi Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S
    Patrick W Sullivan
    University of Colorado Health Sciences Center, School of Pharmacy, Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, Denver, Colorado, USA
    Obesity (Silver Spring) 15:511-21. 2007
  6. ncbi Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, University of Colorado School of Pharmacy, Denver, CO 80262, USA
    Qual Life Res 15:1297-306. 2006
  7. ncbi Productivity costs associated with cardiometabolic risk factor clusters in the United States
    Patrick W Sullivan
    University of Colorado at Denver and Health Sciences Center, Pharmaceutical Outcomes Research Program, School of Pharmacy, 4200 East Ninth Avenue, C238, Denver, CO 80262, USA
    Value Health 10:443-50. 2007
  8. doi The medical cost of cardiometabolic risk factor clusters in the United States
    Patrick W Sullivan
    Pharmaceuticals Outcomes Research Program, University of Colorado at Denver Health Sciences Center, 4200 East Ninth Avenue, C238, Denver, CO 80262, USA
    Obesity (Silver Spring) 15:3150-8. 2007
  9. ncbi Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002
    Patrick W Sullivan
    Department of Clinical Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabetes Care 28:1599-603. 2005
  10. ncbi The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, University of Colorado School of Pharmacy, Department of Clinical Pharmacy, Denver 80262, USA
    Am J Manag Care 11:374-82. 2005

Research Grants

Detail Information

Publications38

  1. ncbi Transitioning the second-generation antihistamines to over-the-counter status: a cost-effectiveness analysis
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, University of Colorado School of Pharmacy, Denver, Colorado 80262, USA
    Med Care 41:1382-95. 2003
    ..The societal impact of transitioning this class of medications from prescription to over-the-counter status has important policy implications...
  2. ncbi The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, School of Pharmacy, University of Colorado at Denver and Health Sciences Center, CO 80262, USA
    Pharmacoeconomics 24:1021-33. 2006
    ....
  3. pmc Preference-Based EQ-5D index scores for chronic conditions in the United States
    Patrick W Sullivan
    University of Colorado Department of Economics, Boulder, USA
    Med Decis Making 26:410-20. 2006
    ..These results highlight the necessity of making a wide array of appropriate, community-based estimates more accessible to cost-effectiveness researchers...
  4. pmc Mapping the EQ-5D index from the SF-12: US general population preferences in a nationally representative sample
    Patrick W Sullivan
    University of Colorado School of Pharmacy, Pharmaceutical Outcomes Research Program, 4200 East Ninth Avenue, Box C238, Denver, CO 80262, USA
    Med Decis Making 26:401-9. 2006
    ..However, preferences based on the general US population are most appropriate for costeffectiveness analyses done from the societal perspective in the United States...
  5. ncbi Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S
    Patrick W Sullivan
    University of Colorado Health Sciences Center, School of Pharmacy, Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, Denver, Colorado, USA
    Obesity (Silver Spring) 15:511-21. 2007
    ....
  6. ncbi Quality of life as a potential predictor for morbidity and mortality in patients with metastatic hormone-refractory prostate cancer
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, University of Colorado School of Pharmacy, Denver, CO 80262, USA
    Qual Life Res 15:1297-306. 2006
    ..The association between HRQL measures with outcomes in patients with metastatic hormone-refractory prostate cancer (HRPC) is unclear...
  7. ncbi Productivity costs associated with cardiometabolic risk factor clusters in the United States
    Patrick W Sullivan
    University of Colorado at Denver and Health Sciences Center, Pharmaceutical Outcomes Research Program, School of Pharmacy, 4200 East Ninth Avenue, C238, Denver, CO 80262, USA
    Value Health 10:443-50. 2007
    ..The purpose of this study was to examine and quantify the impact of cardiometabolic risk factor clusters independent of heart disease on productivity in a nationally representative sample of US adults...
  8. doi The medical cost of cardiometabolic risk factor clusters in the United States
    Patrick W Sullivan
    Pharmaceuticals Outcomes Research Program, University of Colorado at Denver Health Sciences Center, 4200 East Ninth Avenue, C238, Denver, CO 80262, USA
    Obesity (Silver Spring) 15:3150-8. 2007
    ..The prevalence of these cardiometabolic risk factor clusters (CMRFCs) is increasing significantly for all sociodemographic groups, but little is known about their economic impact...
  9. ncbi Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002
    Patrick W Sullivan
    Department of Clinical Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Diabetes Care 28:1599-603. 2005
    ..The objective of this research is to determine the relative associations of physical activity and BMI with the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S...
  10. ncbi The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, University of Colorado School of Pharmacy, Department of Clinical Pharmacy, Denver 80262, USA
    Am J Manag Care 11:374-82. 2005
    ..Numerous prescription products have become available over the counter (OTC) in recent years. Previous simulation models have shown the Rx-to-OTC switch of loratadine to be cost effective...
  11. doi Influence of rheumatoid arthritis on employment, function, and productivity in a nationally representative sample in the United States
    Patrick W Sullivan
    University of Colorado Denver Health Sciences Center, Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, School of Pharmacy, 12631 E 17th Ave, Aurora, CO 80045, USA
    J Rheumatol 37:544-9. 2010
    ....
  12. ncbi Cost-benefit analysis of first-generation antihistamines in the treatment of allergic rhinitis
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, University of Colorado School of Pharmacy, Denver, Colorado 80262, USA
    Pharmacoeconomics 22:929-42. 2004
    ....
  13. ncbi The economic impact of payer policies after the Rx-to-OTC switch of second-generation antihistamines
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, University of Colorado School of Pharmacy, Denver, CO 80262, USA
    Value Health 7:402-12. 2004
    ..The objective of this study was to examine the economic impact of payer policies in response to the Rx-to-OTC switch of loratadine...
  14. ncbi A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, Department of Clinical Pharmacy, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    CNS Drugs 18:911-32. 2004
    ..Patients who experience ADRs from SRIs may seek medical care, require additional treatment, and even discontinue treatment altogether, leading to increased utilisation and cost of therapy...
  15. doi The effect of obesity and cardiometabolic risk factors on expenditures and productivity in the United States
    Patrick W Sullivan
    Department of Clinical Pharmacy, University of Colorado at Denver, Colorado, USA
    Obesity (Silver Spring) 16:2155-62. 2008
    ..To examine the effect of obesity and cardiometabolic risk factors on medical expenditures and missed work days...
  16. doi The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, School of Pharmacy, University of at Denver Colorado and Health Sciences Center, 4200 East Ninth Avenue, C238, Denver, CO, 80262, USA
    Qual Life Res 17:1063-71. 2008
    ..The prevalence of obesity and associated cardiometabolic risk factors such as diabetes, hyperlipidemia and hypertension is increasing significantly for all demographic groups...
  17. ncbi A national catalog of preference-based scores for chronic conditions in the United States
    Patrick W Sullivan
    University of Colorado School of Pharmacy, Pharmaceutical Outcomes Research Program, Denver, Colorado 80262, USA
    Med Care 43:736-49. 2005
    ....
  18. ncbi Quality of life findings from a multicenter, multinational, observational study of patients with metastatic hormone-refractory prostate cancer
    Patrick W Sullivan
    Pharmaceutical Outcomes Research Program, University of Colorado School of Pharmacy, 4200 East Ninth Avenue, Box C238, Denver, CO, 80262, USA
    Qual Life Res 16:571-5. 2007
    ....
  19. ncbi Are health care professionals advising patients with diabetes or at risk for developing diabetes to exercise more?
    Elaine H Morrato
    University of Colorado Health Sciences Center, School of Pharmacy, 4200 East Ninth Avenue, C238, Denver, CO 80262, USA
    Diabetes Care 29:543-8. 2006
    ....
  20. ncbi Inconsistent health perceptions for US women and men with diabetes
    Marianne McCollum
    Department of Clinical Pharmacy, University of Colorado at Denver, and Health Sciences Center, Denver, Colorado, USA
    J Womens Health (Larchmt) 16:1421-8. 2007
    ..Two health status measures for adults with diabetes are compared in order to identify gender-based differences between norm-based scores for health status and self-rated health scores...
  21. doi Asthma in USA: its impact on health-related quality of life
    Patrick W Sullivan
    Regis University School of Pharmacy, Denver, CO, USA
    J Asthma 50:891-9. 2013
    ..The objective of this research is to examine the national burden of asthma and poor asthma control on health function, health perception and preference-based health-related quality of life (HRQL)...
  22. ncbi Physical activity in U.S. adults with diabetes and at risk for developing diabetes, 2003
    Elaine H Morrato
    University of Colorado Health Sciences Center, School of Pharmacy, 4200 East Ninth Avenue, Denver, CO 80262, USA
    Diabetes Care 30:203-9. 2007
    ..Given the risk of obesity and diabetes in the U.S., and clear benefit of exercise in disease prevention and management, this study aimed to determine the prevalence of physical activity among adults with and at risk for diabetes...
  23. ncbi Minor depression and health status among US adults with diabetes mellitus
    Marianne McCollum
    University of Colorado at Denver and Health Sciences Center, School of Pharmacy, Denver, CO 80262, USA
    Am J Manag Care 13:65-72. 2007
    ..To determine whether diabetes mellitus (DM) with minor depression is associated with poorer levels of mental and physical functioning compared with DM without depression...
  24. doi The impact of co-morbidity burden on preference-based health-related quality of life in the United States
    Patrick W Sullivan
    School of Pharmacy, Regis University, Denver, CO 80221, USA
    Pharmacoeconomics 30:431-42. 2012
    ..Many statistical analyses, clinical trials and cost-utility analyses designed to measure the impact of a particular disease on utility scores often overlook the important influence of co-morbidity burden...
  25. ncbi Prevalence of multiple cardiac risk factors in US adults with diabetes
    Marianne McCollum
    School of Pharmacy, University of Colorado at Denver and Health Sciences, Denver, CO 80262, USA
    Curr Med Res Opin 22:1031-4. 2006
    ..This study estimates the national prevalence of additional CHD risk factors for US adults with and without DM and heart disease using Medical Expenditure Panel Survey (MEPS) data...
  26. doi The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey
    Patrick W Sullivan
    Regis University School of Pharmacy, Denver, Colo, USA
    J Allergy Clin Immunol 127:363-369.e1-3. 2011
    ..It is important to have an accurate picture of the sources and extent of medical expenditures and productivity loss to understand the nature and scope of the burden of asthma in the United States (US)...
  27. ncbi Gender differences in diabetes mellitus and effects on self-care activity
    Marianne McCollum
    University of Colorado at Denver and Health Sciences Center, School of Pharmacy, Denver, Colorado 80262, USA
    Gend Med 2:246-54. 2005
    ..Effective self-care, including adherence to diet, exercise, and medication regimens, is an essential component of health care for individuals with diabetes mellitus (DM)...
  28. ncbi Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients
    Robert MacLaren
    School of Pharmacy, C238, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Value Health 8:105-16. 2005
    ..To examine the cost-effectiveness of using recombinant human erythropoietin (rHuEPO) to reduce red blood cells (RBC) transfusions in intensive care unit (ICU) patients...
  29. ncbi Economic evaluation of sustained sedation/analgesia in the intensive care unit
    Robert MacLaren
    University of Colorado at Denver and Health Sciences Center, Department of Clinical Pharmacy, School of Pharmacy, 4200 East Ninth Avenue, Denver, CO 80262, USA
    Expert Opin Pharmacother 7:2047-68. 2006
    ....
  30. pmc Costs and savings associated with community water fluoridation programs in Colorado
    Joan M O'Connell
    University of Colorado at Denver and Health Science Center School of Medicine, Denver, Colo, USA
    Prev Chronic Dis 2:A06. 2005
    ....
  31. doi Catalogue of EQ-5D scores for the United Kingdom
    Patrick W Sullivan
    Regis University, School of Pharmacy, 3333 Regis Blvd, Denver, CO 80221, USA
    Med Decis Making 31:800-4. 2011
    ..Development of a catalogue of EQ-5D scores for a range of health conditions based on UK preferences would help achieve many of these goals...
  32. ncbi Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients
    Robert MacLaren
    Department of Clinical Pharmacy, School of Pharmacy, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA
    Pharmacotherapy 25:1319-28. 2005
    ..To compare the expected costs of short-, intermediate-, and long-term sedation (< 24, 24-72, and > 72 hrs, respectively) with propofol, lorazepam, and midazolam in an intensive care unit...
  33. doi The cost-effectiveness of treatment with desloratadine in patients with persistent allergic rhinitis
    Patrick W Sullivan
    Department of Pharmacy Practice, Regis University, School of Pharmacy, Denver, CO 80221, USA
    Curr Med Res Opin 26:1389-97. 2010
    ..Although the burden of AR is significant, treatment itself is also costly. It is unclear if treatment based on the new definition of PER is cost-effective...
  34. ncbi Therapeutic and economic consequences of OTC loratadine
    Kavita V Nair
    School of Pharmacy, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    Ann Pharmacother 38:169-71. 2004
  35. pmc Cost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
    R Brett McQueen
    Pharmaceutical Outcomes Research Program, School of Pharmacy, University of Colorado Denver, Aurora, Colorado, USA
    Cost Eff Resour Alloc 9:13. 2011
    ..abstract:..
  36. doi Patient-reported health status in coronary heart disease in the United States: age, sex, racial, and ethnic differences
    Jipan Xie
    Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Mailstop K 47, 4770 Buford Hwy NE, Atlanta, GA 30341 3717, USA
    Circulation 118:491-7. 2008
    ..Coronary heart disease (CHD) affects 15.8 million Americans. However, data on the national impact of CHD on health-related quality of life, particularly among people of different age, sex, racial, and ethnic groups, are limited...
  37. ncbi Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics
    John A Nyman
    Division of Health Policy and Management, School of Public Health, University of Minnesota, 520 Delaware Street SE, Minneapolis, MN 55455, USA
    Med Care 45:618-28. 2007
    ..These surveys could be used to conduct cost-utility analyses of health care policies, treatments or other interventions if quality-of-life (QOL) weights for the self-reported health statuses were also available...
  38. pmc Switching prescription drugs to over the counter: consumers may benefit financially in examples from the US
    Patrick W Sullivan
    BMJ 330:904-5. 2005

Research Grants1

  1. HRQL Impact of Chronic Conditions and Comorbidity Burden
    Patrick Sullivan; Fiscal Year: 2006
    ..s. ..